Crysalin

About:

Crysalin is engaged in the research and development of crysalin lattice technologies.

Website: http://www.crysalin.com

Top Investors: IP Group, Longwall Venture, Oxford Technology Management

Description:

Crysalin was founded in June 2007 to research and develop crysalin lattice technology derived from patented work conducted since 2002 in the Oxford University Laboratory of Molecular Biophysics. Crysalins are a protein-based nanotechnology with proven application in protein structure determination. Crysalins demonstrate significant advantages over other methodologies for protein structure determination since they are able to impose order on macromolecular targets to enable X-ray and EM instruments to resolve 3-D molecular structure where current technologies have failed (in particular: membrane proteins, soluble proteins with flexible regions). Crysalins also have the potential for use in biosensor development and optoelectronics.

Total Funding Amount:

$2.4M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2007-06-01

Contact Email:

info(AT)crysalin.com

Founders:

John Sinclair, Martin Noble

Number of Employees:

1-10

Last Funding Date:

2011-01-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai